CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

- Conducted under U.S. FDA-cleared IND - Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie's disease SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- Connext, a clinical stage ...

Patients & methods: The MTD was determined from dose-limiting toxicities in the first cycle. Targeted therapies directed against the ErbB receptor family pathway include antibodies, such as ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

The study was conducted by a group of archaeologists and researchers from the United States and South America, who sought to investigate a centuries-old Chavín compound for evidence of drugs ...

The study revealed stalled progress on ... Steiner added that new ways to drive development should be explored, which include AI. Half of the global respondents said in the survey that they ...

The next step is to initiate translational studies to evaluate the impact of TYK2 inhibition alone or in combination with other already approved drugs in individuals at risk or with recent onset ...

helping lower blood sugar levels — but it’s often hailed as a “wonder drug” by doctors for having many other benefits, including treating fertility issues and PCOS. Studies show that it ...

Pharmaceutical giant Eli Lilly and Co. on Friday announced plans to invest up to $250 million with Purdue over the next eight years, aiming to fast-track drug development and boost Indiana’s ...

A sample of the organization's milestones include: 2005–2010: C-Path quickly emerged as a pioneer in accelerating drug development by launching landmark consortia and earning early regulatory ...

ISLAMABAD: Pakistan has accused India of deliberately altering the flow of the Chenab River — one of the three western rivers allocated to Pakistan under the 1960 Indus Waters Treaty ...